Back to Faculty & Staff

Ashesh Jani, M.D.


Associate Professor of Radiation Oncology

Education and Degrees

  • 1989, Bachelor of Science (B.S.), Electrical Engineering, University of Illinois (at Urbana-Champaign)
  • 1991, Master of Science (M.S.), Electrical and Computer Engineering, University of Illinois (at Urbana-Champaign)     
  • 1995, Doctor of Medicine (M.D.), University of Illinois College of Medicine (at Chicago)

Certification

  • American Board of Radiology, Radiation Oncology, 2001

Training

  • 1995-1996: Rush-Presbyterian-St. Luke's Medical Center (RPSLMC), Chicago, IL,
    Intern (Preliminary Year Resident), Department of Internal Medicine
  • 1996-2000: University of Chicago Hospitals
    Categorical Resident, Department of Radiation and Cellular Oncology         [Chief Resident, 07/1999-06/2000]
    [NIH-NCI/NRSA Research Fellow, 07/1996-06/1997]

Special Interests

I am an academic radiation oncologist, who comes from an electrical engineering background, who is interested in understanding (a) the patient, disease, and treatment factors influencing clinical outcomes, (b) the impact of recently developed technologies on these outcomes, and (c) the design of new technologies [particularly in visualization and radiation treatment planning/delivery] to improve these outcomes.

Selected Recent Publications

o   JJ Sychra, DG Pavel, Y Chen, and A Jani. 1994. "The Accuracy of SPECT Brain Activation Images. Part I: Propagation of Registration Errors." Medical Physics. 21(10): 1585-1590.

 

o   AB Jani and JJ Sychra. 1995. "MR Image Classification Algorithms for Neurosurgical and Stereotactic Radiosurgical Trajectory Planning and Volumetric Analysis." Neurological Research. 17(1): 17-23.

 

o   AB Jani, CA Pelizzari, GTY Chen, RP Grzeszczuk, and S Vijayakumar. 1997. "Interactive Tool for Evaluating the Utility of Volume-Rendered Images Versus Sagittal Plane-Picked Images of the Prostate for Radiotherapy Treatment Planning." RSNA Electronic Journal. 1(1), http://ej.rsna.org [online journal – no page numbers].

 

o   AB Jani, CA Pelizzari, GTY Chen, and RP Grzeszcuk. 1998. "Accuracy of Object Depiction and Opacity Transfer Function Optimization in CT Volume-Rendered Images." Journal of Computer Assisted Tomography. 22(3): 459-470.

 

o   JS Lee, AB Jani, CA Pelizzari, DJ Haraf, RR Weichselbaum, and GTY Chen. 1999. "Volumetric Rendering of Head and Neck CT Data for Treatment Planning." International Journal of Radiation Oncology, Biology, and Physics. 44(3): 693-703.

 

o   AB Jani, M Chen, F Vaida, L Ignacio, A Awan, RR Weichselbaum, and S Vijayakumar. 1999. "PSA-Based Outcome Analysis After Radiation Therapy for Prostate Cancer: a New Definition of Biochemical Failure After Intervention." Urology. 54: 700-705.

 

o   AB Jani, CA Pelizzari, GTY Chen, JC Roeske, RJ Hamilton, L Macdonald, F Bova, KR Hoffmann, and PA Sweeney. 2000. "Volume Rendering Quantification Algorithm for Reconstruction of CT Volume Rendered Structures: I. Cerebral Arteriovenous Malformations." IEEE Transactions on Medical Imaging. 19(1): 12-24.

 

o   AB Jani, PP Connell, VJ Vesich, KM O'Brien, and LM Chen. 2000. "An Analysis of the Impact of Adjuvant Chemotherapy for Invasive Carcinoma of the Esophagus." American Journal of Clinical Oncology (Cancer Clinical Trials). 23(6): 544-548.

 

o   PP Connell, L Ignacio, D Haraf, AM Awan, H Halpern, I Abdalla, J Nautiyal, AB Jani, RR Weichselbaum, and S Vijayakumar. 2001. “Equivalent Racial Outcome Following Conformal Radiotherapy for Prostate Cancer: A Single Departmental Experience.” Journal of Clinical Oncology. 19(1): 54-61.  

 

o   A Jani and N Vogelzang. 2001. “Re: Neoadjuvant Hormonal Ablative Therapy Before Radical Prostatectomy: A Review. Is it Indicated?” Journal of Urology. 166(2): 631-632.

 

o   AB Jani, F Vaida, G Hanks, S Asbell, O Sartor, JW Moul, M Roach, D Brachman, U Kalokhe, R Muller-Runkel, P Ray, L Ignacio, A Awan, RR Weichselbaum, and S Vijayakumar. 2001. "The Changing ‘Face’ and Different ‘Countenances’ of Prostate Cancer: Racial and Geographic Differences in PSA, Stage, and Grade Trends in the PSA Era.” International Journal of Cancer (Radiation Oncology Investigations). 96(6): 363-371.

 

o   I Abdalla, L Ignacio, F Vaida, M Chen, A Awan, A Jani, C Mamo, RR Weichselbaum, and S Vijayakumar. 2002. “Evolution of Toxicity after Conformal Radiotherapy for Prostate Cancer.” Prostate Cancer and Prostatic Diseases. 5(4): 296-303.

 

o   AB Jani, A Basu, R Heimann, and S Hellman. 2003. “Sentinel Node versus Axillary Node Dissection for Early Stage Breast Cancer: A Comparison Using a Utility-Adjusted Number Needed to Treat (NNT) Analysis.” Cancer. 97(2): 359-366.

 

o   AB Jani, CM Hand, CA Pelizzari, JC Roeske, L Krauz, and S Vijayakumar. 2003. “Biological Effective versus Conventional Dose Volume Histograms Correlated with Late Gastrointestinal and Genitourinary Toxicity after External Beam Radiotherapy for Prostate Cancer: A Matched-Pair Analysis.” BMC Cancer. 3(16) [online – no page numbers].

 

o   J Levitsky, JJ Hong, AB Jani, and ED Ehrenpreis. 2003. “Oral Vitamin A Therapy for a Patient with a Severely Symptomatic Post-Radiation Anal Ulceration: Report of a Case.” Diseases of the Colon and Rectum. 46(5): 679-682.

 

o   AB Jani. 2003. “Organ Motion and IMRT in Prostate Cancer Therapy [Re: Reduction in Acute Morbidity using Hypofractionated Intensity Modulated Radiotherapy Assisted with a Fluoroscopic Real-time Tumor Tracking System for Prostate Cancer: Preliminary results of a Phase I/II Study].” The Cancer Journal. 9(4): 244-246..

 

o   AB Jani, A Basu, I Abdalla, L Krauz, PP Connell, and S Vijayakumar. 2003. “The Impact of Hormone Therapy When Combined with External Beam Radiotherapy for Early-Stage, Intermediate- or High-Risk Prostate Cancer.” American Journal of Clinical Oncology (Cancer Clinical Trials). 26(4): 382-385.

 

o   AB Jani, J Kao, and S Hellman. 2003. “Hormone Therapy Adjuvant to External Beam Radiotherapy for Locally Advanced Prostate Cancer: A Utility-Adjusted Number-Needed to Treat (NNT) Analysis.” Cancer. 98(11): 2351-2361.

 

o   R Singh, H Al-Hallaq, CA Pelizzari, GP Zagaja, AA Chen, and AB Jani. 2003. “Dosimetric Quality Endpoints for Low-Dose-Rate Prostate Brachytherapy Using Biological Effective Dose (BED) vs. Conventional Dose.” Medical Dosimetry. 28(4): 255-259.

 

o   AB Jani, D Spelbring, R Hamilton, MJ Blend, CA Pelizzari, C Brendler, L Krauz, S Vijayakumar, B Sapra, and RR Weichselbaum. 2004. “Impact of Radioimmunoscintigraphy on Definition of Clinical Target Volume for Radiotherapy after Prostatectomy.” Journal of Nuclear Medicine. 45(2): 238-246.

 

o   J Kao, J Turian, A Meyers, RJ Hamilton, B Smith, S Vijayakumar, and AB Jani. 2004. “Sparing of the Penile Bulb and Proximal Penile Structures with Intensity Modulated Radiation Therapy for Prostate Cancer.” British Journal of Radiology. 77(914): 129-136.

 

o   AB Jani, CM Hand, AE Lujan, JC Roeske, GP Zagaja, S Vijayakumar, and CA Pelizzari. 2004. “Biological Effective Dose for Comparison and Combination of External Beam and Low-Dose Rate Interstitial Brachytherapy Prostate Cancer Treatment Plans.” Medical Dosimetry. 29(1): 42-48.

 

o   AB Jani, MJ Blend, R Hamilton, C Brendler, CA Pelizzari, L Krauz, S Vijayakumar, B Sapra, A Awan, and RR Weichselbaum. 2004. “The Influence of Radioimmunoscintigraphy on Post-Prostatectomy Radiotherapy Treatment Decision-Making.” Journal of Nuclear Medicine. 45(4): 571-578. 

 

o   AB Jani, LC Myrianthopoulos, and S Vijayakumar. 2004. “The Application of NNT (Number Needed to Treat) to Clinical Problems in Radiotherapy.” Cancer Investigation. 22(2): 262-270.

 

o   MT Milano, SJ Chmura, MC Garofalo, C Rash, JC Roeske, O Kwon, PP Connell, AB Jani, and R Heimann. 2004. “Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Pancreatic and Bile Duct Malignancies: Toxicity and Clinical Outcome.” International Journal of Radiation Oncology, Biology, and Physics. 59(2): 445-453.

 

o   AB Jani, A Al-Qamari, B Sapra, L Krauz, A Awan, M Kocherginsky, and D Gillen. 2004. “Analysis of Prostate Specific Antigen Rebound Interval in Prostate Cancer Patients Receiving Hormones and External Beam Radiotherapy.” Clinical Prostate Cancer. 3(1): 43-48.

 

o   J Kao, AB Jani, and S Vijayakumar. 2004. “Is there an Association between Multiple Myeloma and Prostate Cancer?” Medical Hypotheses. 63(2): 226-231.

 

o   AB Jani, MJ Blend, R Hamilton, C Brendler, CA Pelizzari, L Krauz, B Sapra, S Vijayakumar, A Awan, and RR Weichselbaum. 2004. “Radioimmunoscintigraphy for Post-Prostatectomy Radiotherapy: Analysis of Toxicity and Biochemical Control.” Journal of Nuclear Medicine. 45(8): 1315-1322.

 

o   AB Jani, M Sokoloff, A Shalhav, and W Stadler. 2004. “Androgen Ablation Adjuvant to Post-Prostatectomy Radiotherapy: A Complication-Adjusted Number-Needed to Treat Analysis.” Urology. 64(5): 976-981.

 

o   WH Hall, R Ramachandran, S Narayan, AB Jani, and S Vijayakumar. 2004. “An Electronic Application for Rapidly Calculating Charlson Comorbidity Score.” BMC Cancer. 4(1): 94.

 

o   KD Chi, ED Ehrenpreis, and AB Jani. 2005. “Accuracy and Reliability of the Endoscopic Classification of Chronic Radiation-Induced Proctopathy using a Novel Grading Method.” Journal of Clinical Gastroenterology. 39(1): 42-46.

 

o   ME Lacouture, JM Baron, AB Jani, AE Laumann, and K Soltani. 2005. “Treatment of Radiation-Relapsing Primary Cutaneous B-Cell Lymphoma with Anti-CD20 Monoclonal Antibody.” Clinical and Experimental Dermatology. 30(1): 46-48.

 

o   ED Ehrenpreis, A Jani, J Levitsky, J Ahn, and J Hong. 2005. “A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy.” Diseases of the Colon and Rectum. 48(1): 1-8.

 

o   AB Jani, J Gratzle, E Muresan, and MK Martel. 2005. “Impact on Late Toxicity of using Transabdominal Ultrasound for Prostate Cancer Patients Treated with Intensity Modulated Radiotherapy.” Technology in Cancer Research and Treatment. 4(1): 115-120.

 

o   WH Hall, AB Jani, JK Ryu, S Narayan, S Vijayakumar. 2005. “The Impact of Age and Comorbidity on Survival Outcomes and Treatment Patterns in Prostate Cancer.” Prostate Cancer and Prostatic Diseases. 8(1):22-30..

 

o   AB Jani, J Kao, R Heimann, and S Hellman. 2005. “Hormone Therapy Adjuvant to External Beam Radiotherapy for Early Prostate Cancer: A Complication-Adjusted Number-Needed to Treat (NNT) Analysis.” International Journal of Radiation Oncology, Biology, and Physics. 61(3): 687-694.

 

o   AB Jani, J Gratzle, E Muresan, K Farrey, and MK Martel. 2005. “Analysis of Acute Toxicity with the Use of Transabdominal Ultrasound for Prostate Positioning during Intensity-Modulated Radiotherapy Treatment.” Urology. 65(3): 504-508.

 

o   AB Jani and J Kao. 2005. “Adjuvant versus Salvage Post-Prostatectomy Radiotherapy: A Complication-Adjusted Number Needed to Treat Analysis.” Cancer. 103(9): 1833-1842.

 

o   AB Jani, SD Parikh, S Vijayakumar, and J Gratzle. 2005. “Analysis of the Influence of Age on Acute and Chronic Radiotherapy Toxicity in Treatment of Prostate Cancer.” Urology. 65(6): 1157-1162.

 

o   AB Jani, JS Irick, and C Pelizzari. 2005. “Opacity Transfer Function Optimization for Volume Rendered Computed Tomography Images of the Prostate.” Academic Radiology. 12(6): 761-770.

 

o   AB Jani and J Gratzle. 2005.  “Analysis of the Impact of Age and Race on Prostate Cancer Biochemical Control after Radiotherapy in Different Prostate Cancer Settings.” Urology. 66(1): 124-129.

 

o   AB Jani, J Gratzle, and M Myers. 2005. “Impact of Hormone Therapy on Acute Radiotherapy Toxicity in the Treatment of Prostate Cancer.” Prostate Cancer and Prostatic Diseases. 8(3): 224-228.

 

o   A Su, C Reft, C Rash, J Price, and AB Jani. 2005. “A Case Study of Radiotherapy Planning for a Bilateral Metal Hip Prosthesis Prostate Cancer Patient.” Medical Dosimetry. 30(3): 169-175.

 

o   AB Jani and J Gratzle. 2005. “Late Radiotherapy Toxicity after Prostate Cancer Treatment: Influence of Hormonal Therapy.” Urology. 66(3): 566-570.

 

o   AB Jani. 2005.“The Significance of Symptomatic Recurrence after Prostate Radiotherapy.” American Journal of Oncology Review. 4 (9 Suppl 11): 29-30.

 

o   MT Milano, AB Jani, KJ Farrey, C Rash, R Heimann, and SJ Chmura. 2005. “Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Anal Cancer: Toxicity and Clinical Outcome.” International Journal of Radiation Oncology, Biology, and Physics. 63(2): 354-361.

 

o   V Damerla, S Packianathan, PS Boerner, AB Jani, S Vijayakumar, and V Vijayakumar. 2005. “Recent Developments in Nuclear Medicine in the Management of Bone Metastases: A Review and Perspective.” American Journal of Clinical Oncology (Cancer Clinical Trials). 28(5): 513-520.

 

o   AB Jani, A Su, and MT Milano. 2006. “Intensity Modulated versus Conventional Pelvic Radiotherapy for Prostate Cancer: Analysis of Acute Toxicity.” Urology. 67(1): 147-151.

 

o   A Su, MJ Blend, D Spelbring, RJ Hamilton, and AB Jani. 2006. “Post-prostatectomy Target-Normal Structure Overlap Volumes Using Computed Tomography and Radioimmuno-scintigraphy Images for Radiotherapy Treatment Planning.” Clinical Nuclear Medicine. 31(3): 139-144.

 

o   AB Jani. 2006. “Approaching Clinical Problems in Prostate Cancer Radiotherapy Using the Number Needed to Treat (NNT) Technique.” Cancer Investigation. 24(3): 318-327.

 

o   AB Jani, JM Feinstein, R Pasciak, S Krengel, and RR Weichselbaum. 2006. “The Role of External Beam Radiotherapy with Low Dose Rate Brachytherapy in the Treatment of Prostate Cancer.” Urology. 67(5): 1007-1011. 

 

o   MT Milano, MC Garofalo, SJ Chmura, K Farrey, C Rash, R Heimann, and AB Jani. 2006. “Intensity Modulated Radiation Therapy (IMRT) for Stomach Cancer: Early Clinical Outcome and Dosimetric Comparison.” British Journal of Radiology. 79(942): 497-503.

 

o   AB Jani and J Gratzle. 2006 “Biochemical Control Impact of Hormone Therapy Adjuvant to Radiotherapy in Different Prostate Cancer Settings.” American Journal of Cancer. 5(3): 193-198.

 

o   AB Jani, A Su, D Correa, and J Gratzle. 2006. “Comparison of Late Gastrointestinal and Genitourinary Toxicity of Prostate Cancer Patients Undergoing Intensity-Modulated versus Conventional Radiotherapy Using Localized Fields.” Prostate Cancer and Prostatic Diseases. (accepted).

 

o   B Knab, C Rash, K Farrey, and AB Jani.2006. “Intensity-Modulated Radiotherapy for Neoadjuvant Treatment of Gastric Cancer.” Medical Dosimetry. (accepted).